Please select the option that best describes you:

For patients who require aggressive debulking in multiple myeloma, what is your preferred chemotherapy regimen and why?  

Modified HyperCVAD? V(R)D-PACE? DCEP? Are there any data to favor one over the other?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Love this, and completely agree! Every patient who...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
This is excellently stated on all fronts - I compl...
Medical Oncologist at University of Chicago
I dose cyclophosphamide 2 g/m² in two doses, ...
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Thank you, this is very helpful - likely the simpl...
Medical Oncologist at Virginia Mason Medical Center
For upfront therapy and assuming adequate renal fu...
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Completely agree with this excellent clarification...
Medical Oncologist at Winship Cancer Institute of Emory University
Along @Ben Derman's thoughts, remember that VDT-PA...
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Very well stated, @Craig C. Hofmeister - hear hear...
Sign in or Register to read more